PMID- 8622597 OWN - NLM STAT- MEDLINE DCOM- 19960618 LR - 20190725 IS - 0026-0495 (Print) IS - 0026-0495 (Linking) VI - 45 IP - 5 DP - 1996 May TI - Lysophosphatidylcholine stimulates the expression and production of MCP-1 by human vascular endothelial cells. PG - 559-64 AB - Lysophosphatidylcholine (LPC increased monocyte chemoattractant protein-1 (MCP-1) messenger RNA concentrations in human umbilical vein endothelial cells (HUVECs). A time-course study showed that the increase in MCP-1 mRNA levels peaked at 6 hours after treatment with LPC. The effect of LPC on the accumulation of MCP-I mRNA levels in HUVECs depended on LPC concentration, and the maximal effect was obtained at 50 micromol / L LPC, which induced a sixfold increase in MCP-1 mRNA levels. The amount of MCP-1 released from HUVECs measured using an enzyme-linked immunosorbent assay (ELISA) showed a 38% increase in the presence of 50 micromol/L LPC, but not in the presence of phosphatidylcholine or lysophosphatidylethanolamine. Coincubation with staurosporine, a potent inhibitor of protein kinase C (PKC) activity, attenuated the LPC-induced increase in MCP-1 mRNA levels by 53%. These results indicate that LPC can induce an increase in MCP-1 mRNA concentrations and stimulate the release of MCP-1 protein from HUVECs, and that the effect of LPC on the MCP-1 gene may be mediated through activation of the PKC pathway. FAU - Takahara, N AU - Takahara N AD - Third Department of Medicine, Shiga University of Medical Science, Japan. FAU - Kashiwagi, A AU - Kashiwagi A FAU - Maegawa, H AU - Maegawa H FAU - Shigeta, Y AU - Shigeta Y LA - eng PT - Journal Article PL - United States TA - Metabolism JT - Metabolism: clinical and experimental JID - 0375267 RN - 0 (Chemokine CCL2) RN - 0 (Lysophosphatidylcholines) RN - 0 (Oligodeoxyribonucleotides) RN - 0 (RNA, Messenger) RN - EC 2.7.11.13 (Protein Kinase C) SB - IM MH - Base Sequence MH - Cells, Cultured MH - Chemokine CCL2/biosynthesis/*genetics MH - Endothelium, Vascular/cytology/*drug effects/metabolism MH - Gene Expression Regulation/drug effects MH - Humans MH - Kinetics MH - Lysophosphatidylcholines/*pharmacology MH - Molecular Sequence Data MH - Oligodeoxyribonucleotides MH - Protein Kinase C/antagonists & inhibitors MH - RNA, Messenger/genetics/metabolism EDAT- 1996/05/01 00:00 MHDA- 1996/05/01 00:01 CRDT- 1996/05/01 00:00 PHST- 1996/05/01 00:00 [pubmed] PHST- 1996/05/01 00:01 [medline] PHST- 1996/05/01 00:00 [entrez] AID - S0026-0495(96)90024-4 [pii] AID - 10.1016/s0026-0495(96)90024-4 [doi] PST - ppublish SO - Metabolism. 1996 May;45(5):559-64. doi: 10.1016/s0026-0495(96)90024-4.